A total of 612 patients (85.7%) were positive for ER, 398 patients (55.4%) were positive for PgR, and 621 patients (86.3%) were classified as having HR+ breast cancer, which represented the majority of cases. The gene discussed is ESR1; the disease is breast cancer.